Sanofi-Aventis Sees A Bright Future In Boston-Cambridge
BOSTON (CBS) - Just a little more than a year since Sanofi-Aventis of Paris completed its acquisition of Genzyme of Cambridge, the company's CEO says he's ready to make more investments in the area.
Sanofi CEO Chris Viehbacher says research departments have been consolidated here to be near universities.
WBZ NewsRadio 1030's Anthony Silva reports
Podcast
Viehbacher says Sanofi and Genzyme are making the Cambridge-Boston area the company's key platform for research.
Viehbacher tells me he thinks that Genzyme's strong footprint will continue to grow internally and externally.
